Stem cell-based organ replacements-Airway and lung tissue engineering

Jonathan M. Fishman, Mark Lowdell, Martin A. Birchall

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Tissue engineering requires the use of cells seeded onto scaffolds, often in conjunction with bioactive molecules, to regenerate or replace tissues. Significant advances have been made in recent years within the fields of stem cell biology and biomaterials, leading to some exciting developments in airway tissue engineering, including the first use of stem cell-based tissue-engineered tracheal replacements in humans. In addition, recent advances within the fields of scaffold biology and decellularization offer the potential to transplant patients without the use of immunosuppression.

Original languageEnglish (US)
JournalSeminars in Pediatric Surgery
Volume23
Issue number3
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Tissue Engineering
Stem Cells
Lung
Biocompatible Materials
Immunosuppression
Cell Biology
Transplants

Keywords

  • Airway management
  • Artificial organs
  • Biocompatible materials
  • Bioreactors
  • Larynx
  • Regenerative medicine
  • Stem cells
  • Tissue engineering
  • Tissue scaffolds
  • Trachea
  • Transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Surgery

Cite this

Stem cell-based organ replacements-Airway and lung tissue engineering. / Fishman, Jonathan M.; Lowdell, Mark; Birchall, Martin A.

In: Seminars in Pediatric Surgery, Vol. 23, No. 3, 2014.

Research output: Contribution to journalArticle

Fishman, Jonathan M. ; Lowdell, Mark ; Birchall, Martin A. / Stem cell-based organ replacements-Airway and lung tissue engineering. In: Seminars in Pediatric Surgery. 2014 ; Vol. 23, No. 3.
@article{3023610b22064473a13838451df37894,
title = "Stem cell-based organ replacements-Airway and lung tissue engineering",
abstract = "Tissue engineering requires the use of cells seeded onto scaffolds, often in conjunction with bioactive molecules, to regenerate or replace tissues. Significant advances have been made in recent years within the fields of stem cell biology and biomaterials, leading to some exciting developments in airway tissue engineering, including the first use of stem cell-based tissue-engineered tracheal replacements in humans. In addition, recent advances within the fields of scaffold biology and decellularization offer the potential to transplant patients without the use of immunosuppression.",
keywords = "Airway management, Artificial organs, Biocompatible materials, Bioreactors, Larynx, Regenerative medicine, Stem cells, Tissue engineering, Tissue scaffolds, Trachea, Transplantation",
author = "Fishman, {Jonathan M.} and Mark Lowdell and Birchall, {Martin A.}",
year = "2014",
doi = "10.1053/j.sempedsurg.2014.04.002",
language = "English (US)",
volume = "23",
journal = "Seminars in Pediatric Surgery",
issn = "1055-8586",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Stem cell-based organ replacements-Airway and lung tissue engineering

AU - Fishman, Jonathan M.

AU - Lowdell, Mark

AU - Birchall, Martin A.

PY - 2014

Y1 - 2014

N2 - Tissue engineering requires the use of cells seeded onto scaffolds, often in conjunction with bioactive molecules, to regenerate or replace tissues. Significant advances have been made in recent years within the fields of stem cell biology and biomaterials, leading to some exciting developments in airway tissue engineering, including the first use of stem cell-based tissue-engineered tracheal replacements in humans. In addition, recent advances within the fields of scaffold biology and decellularization offer the potential to transplant patients without the use of immunosuppression.

AB - Tissue engineering requires the use of cells seeded onto scaffolds, often in conjunction with bioactive molecules, to regenerate or replace tissues. Significant advances have been made in recent years within the fields of stem cell biology and biomaterials, leading to some exciting developments in airway tissue engineering, including the first use of stem cell-based tissue-engineered tracheal replacements in humans. In addition, recent advances within the fields of scaffold biology and decellularization offer the potential to transplant patients without the use of immunosuppression.

KW - Airway management

KW - Artificial organs

KW - Biocompatible materials

KW - Bioreactors

KW - Larynx

KW - Regenerative medicine

KW - Stem cells

KW - Tissue engineering

KW - Tissue scaffolds

KW - Trachea

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=84903462502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903462502&partnerID=8YFLogxK

U2 - 10.1053/j.sempedsurg.2014.04.002

DO - 10.1053/j.sempedsurg.2014.04.002

M3 - Article

VL - 23

JO - Seminars in Pediatric Surgery

JF - Seminars in Pediatric Surgery

SN - 1055-8586

IS - 3

ER -